231 related articles for article (PubMed ID: 9146340)
1. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.
Vansteenkiste JF; De Leyn PR; Deneffe GJ; Stalpaert G; Nackaerts KL; Lerut TE; Demedts MG
Ann Thorac Surg; 1997 May; 63(5):1441-50. PubMed ID: 9146340
[TBL] [Abstract][Full Text] [Related]
2. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
Martini N; Rusch VW; Bains MS; Kris MG; Downey RJ; Flehinger BJ; Ginsberg RJ
J Thorac Cardiovasc Surg; 1999 Jan; 117(1):32-6; discussion 37-8. PubMed ID: 9869756
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.
Chapelier A; Fadel E; Macchiarini P; Lenot B; Le Roy Ladurie F; Cerrina J; Dartevelle P
Eur J Cardiothorac Surg; 2000 Nov; 18(5):513-8. PubMed ID: 11053809
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
8. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognosis of resected T3 non-small cell lung cancer.
Riquet M; Lang-Lazdunski L; Le PB; Dujon A; Souilamas R; Danel C; Manac'h D
Ann Thorac Surg; 2002 Jan; 73(1):253-8. PubMed ID: 11834019
[TBL] [Abstract][Full Text] [Related]
10. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
11. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
13. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
16. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
20. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
